MX2022002105A - Imagenologia por resonancia magnetica (mri) sensible a neuromelanina para la evaluacion de la enfermedad de parkinson. - Google Patents

Imagenologia por resonancia magnetica (mri) sensible a neuromelanina para la evaluacion de la enfermedad de parkinson.

Info

Publication number
MX2022002105A
MX2022002105A MX2022002105A MX2022002105A MX2022002105A MX 2022002105 A MX2022002105 A MX 2022002105A MX 2022002105 A MX2022002105 A MX 2022002105A MX 2022002105 A MX2022002105 A MX 2022002105A MX 2022002105 A MX2022002105 A MX 2022002105A
Authority
MX
Mexico
Prior art keywords
neuromelanin
disease
parkinson
sensitive mri
mri
Prior art date
Application number
MX2022002105A
Other languages
English (en)
Inventor
Samuel Clark
Hernandez Guillermo Horga
Clifford Mills Cassidy
Kenneth Wengler
Original Assignee
Terran Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terran Biosciences Inc filed Critical Terran Biosciences Inc
Publication of MX2022002105A publication Critical patent/MX2022002105A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves  involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4082—Diagnosing or monitoring movement diseases, e.g. Parkinson, Huntington or Tourette
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0033—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room
    • A61B5/0035—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room adapted for acquisition of images from more than one imaging mode, e.g. combining MRI and optical tomography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0033—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room
    • A61B5/004—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part
    • A61B5/0042—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part for the brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4842—Monitoring progression or stage of a disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computed tomography [CT]
    • A61B6/037—Emission tomography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5608—Data processing and visualization specially adapted for MR, e.g. for feature analysis and pattern recognition on the basis of measured MR data, segmentation of measured MR data, edge contour detection on the basis of measured MR data, for enhancing measured MR data in terms of signal-to-noise ratio by means of noise filtering or apodization, for enhancing measured MR data in terms of resolution by means for deblurring, windowing, zero filling, or generation of gray-scaled images, colour-coded images or images displaying vectors instead of pixels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Radiology & Medical Imaging (AREA)
  • High Energy & Nuclear Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Physiology (AREA)
  • Developmental Disabilities (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Optics & Photonics (AREA)

Abstract

Una técnica, un método y un medio accesible por computadora de imagenología por resonancia magnética ("MRI") sensible a la neuromelanina para medir el alcance, proporcionar un diagnóstico, monitorear el tratamiento, evaluar nuevos tratamientos o determinar un pronóstico relacionado con la enfermedad de Parkinson.
MX2022002105A 2019-08-20 2020-08-17 Imagenologia por resonancia magnetica (mri) sensible a neuromelanina para la evaluacion de la enfermedad de parkinson. MX2022002105A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962889300P 2019-08-20 2019-08-20
PCT/US2020/046686 WO2021034770A1 (en) 2019-08-20 2020-08-17 Neuromelanin-sensitive mri for assessing parkinson's disease

Publications (1)

Publication Number Publication Date
MX2022002105A true MX2022002105A (es) 2022-08-04

Family

ID=74660631

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022002105A MX2022002105A (es) 2019-08-20 2020-08-17 Imagenologia por resonancia magnetica (mri) sensible a neuromelanina para la evaluacion de la enfermedad de parkinson.

Country Status (10)

Country Link
US (1) US20220273184A1 (es)
EP (1) EP4018202A4 (es)
JP (1) JP2022545083A (es)
KR (1) KR20220100851A (es)
CN (1) CN114787631A (es)
AU (1) AU2020334980A1 (es)
CA (1) CA3151632A1 (es)
IL (1) IL290693A (es)
MX (1) MX2022002105A (es)
WO (1) WO2021034770A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11293852B2 (en) 2016-04-07 2022-04-05 The General Hospital Corporation White blood cell population dynamics
TWI781463B (zh) * 2020-10-15 2022-10-21 臺北醫學大學 腦部多巴胺轉運體檢查系統及其運作方法
WO2022192728A2 (en) * 2021-03-11 2022-09-15 Terran Biosciences, Inc. Systems, devices, and methods for harmonization of imaging datasets including biomarkers
WO2022266654A1 (en) * 2021-06-16 2022-12-22 The General Hospital Corporation Methods to characterize functional and dysfunctional acute inflammatory responses to pathologic processes
WO2023039283A1 (en) * 2021-09-13 2023-03-16 Rourk Christopher J Deep brain sensing and stimulation probe
WO2023235766A2 (en) * 2022-05-31 2023-12-07 University Of Ottawa Institute Of Mental Health Research Methods for acquiring and analyzing neuromelanin-sensitive mri
US20230414125A1 (en) * 2022-06-23 2023-12-28 ViBo Health LLC Health Trackers for Autonomous Targeting of Tissue Sampling Sites
CN114999657A (zh) * 2022-08-03 2022-09-02 首都医科大学附属北京友谊医院 评估帕金森病患者的神经纤维束与步态障碍的相关性的方法和相关产品
WO2024040167A2 (en) * 2022-08-18 2024-02-22 Arizona Board Of Regents On Behalf Of The University Of Arizona Selective mc4r ligand for treating obesity and cognitive loss
WO2024081800A1 (en) * 2022-10-12 2024-04-18 Octave Bioscience, Inc. Measuring brain volumes for modeling neurological disease state
CN116740064B (zh) * 2023-08-14 2023-10-20 山东奥洛瑞医疗科技有限公司 一种核磁共振肿瘤区域提取方法
CN117372437B (zh) * 2023-12-08 2024-02-23 安徽农业大学 用于面神经麻痹智能化检测与量化方法及其系统

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288545B1 (en) * 1999-03-22 2001-09-11 General Electric Company Method and apparatus for calibration of RF and gradient field time delays
US20050260577A1 (en) * 2000-10-09 2005-11-24 Kay Double Detection of neurodegenerative disorders
US20070275944A1 (en) * 2006-04-05 2007-11-29 The Board Of Trustees Operating Michigan State University Antioxidants and methods of their use
EP2844143B1 (en) * 2012-05-04 2023-07-19 Emory University Method for imaging and determining information associated with regions of the brain
EP3017400B1 (en) * 2013-07-02 2019-05-15 Surgical Information Sciences Inc. Method and system for a brain image pipeline and brain image region location and shape prediction
US20150023877A1 (en) * 2013-07-18 2015-01-22 The Board Of Trustees Of The Leland Stanford Junior University Methods of parkinsons disease diagnosis and monitoring treatment
BR112017021098A2 (pt) * 2015-04-02 2018-07-03 Crc For Mental Health Ltd método para prever risco de deterioração cognitiva
US11352671B2 (en) * 2015-05-01 2022-06-07 Vanderbilt University Predicting therapeutic response in Parkinson's disease
WO2017053718A2 (en) * 2015-09-23 2017-03-30 Boston Medical Center Corporation Biomarkers for the early detection of parkinson's disease
WO2018119766A1 (zh) * 2016-12-28 2018-07-05 上海联影医疗科技有限公司 多模态图像处理系统及方法
AU2019319837A1 (en) * 2018-08-07 2021-02-25 Likeminds, Inc. Method for diagnosis of dopaminergic and movement disorders

Also Published As

Publication number Publication date
CA3151632A1 (en) 2021-02-25
CN114787631A (zh) 2022-07-22
IL290693A (en) 2022-04-01
WO2021034770A1 (en) 2021-02-25
EP4018202A4 (en) 2023-11-01
EP4018202A1 (en) 2022-06-29
JP2022545083A (ja) 2022-10-25
KR20220100851A (ko) 2022-07-18
US20220273184A1 (en) 2022-09-01
AU2020334980A1 (en) 2022-03-03

Similar Documents

Publication Publication Date Title
MX2022002105A (es) Imagenologia por resonancia magnetica (mri) sensible a neuromelanina para la evaluacion de la enfermedad de parkinson.
MX2023005649A (es) Irm sensible a la neuromelanina y metodos de uso de esta.
Hong et al. Multimodal MRI profiling of focal cortical dysplasia type II
Bernhardt et al. The spectrum of structural and functional imaging abnormalities in temporal lobe epilepsy
Chen et al. Head impulse gain and saccade analysis in pontine-cerebellar stroke and vestibular neuritis
Feng et al. Corticospinal tract lesion load: an imaging biomarker for stroke motor outcomes
Fehlner et al. Higher‐resolution MR elastography reveals early mechanical signatures of neuroinflammation in patients with clinically isolated syndrome
Maraka et al. Degree of corticospinal tract damage correlates with motor function after stroke
Barysheva et al. White matter microstructural abnormalities in bipolar disorder: A whole brain diffusion tensor imaging study
MX2019005955A (es) Sistemas y metodos para deteccion automatizada en imagenes de resonancia magnetica.
Liu et al. Whole brain white matter changes revealed by multiple diffusion metrics in multiple sclerosis: a TBSS study
Yoo et al. Correlation of magnetic resonance diffusion tensor imaging and clinical findings of cervical myelopathy
Somers et al. The measurement of language lateralization with functional transcranial Doppler and functional MRI: a critical evaluation
WO2018027298A1 (en) Portable alzheimer detector
Caglic et al. Defining the incremental value of 3D T2-weighted imaging in the assessment of prostate cancer extracapsular extension
Hall et al. An evaluation of kurtosis beamforming in magnetoencephalography to localize the epileptogenic zone in drug resistant epilepsy patients
IL282211A (en) A system, method, and computer-accessible medium for neuromelanin-sensitive magnetic resonance imaging as a noninvasive proxy measure of dopamine function in the human brain
Meyer et al. ADC values of benign and high grade meningiomas and associations with tumor cellularity and proliferation–A systematic review and meta-analysis
Nissan et al. Diffusion tensor magnetic resonance imaging of the pancreas
Deleo et al. Whole-brain multimodal MRI phenotyping of periventricular nodular heterotopia
Gardner et al. Quantitative and morphologic change associated with breast cancer-related lymphedema. Comparison of 3.0 T MRI to external measures
Huffnagel et al. Longitudinal diffusion MRI as surrogate outcome measure for myelopathy in adrenoleukodystrophy
Ono et al. Mesial temporal lobe epilepsy: revisiting the relation of hippocampal volumetry with memory deficits
Gotschy et al. Local versus global aortic pulse wave velocity in early atherosclerosis: An animal study in ApoE-/--mice using ultrahigh field MRI
CN111526788A (zh) 用于疾病的早期检测及标定严重程度的非侵入性成像方法